[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://global.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 1543, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 1329651, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Joseph Trizzino B.S., M.B.A.", "age": 64, "title": "President & COO", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 670550, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 58, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 716175, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Casey", "age": 61, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 137357, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 53, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 61, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Silvia  Taylor M.B.A.", "title": "Executive VP and Chief Corporate Affairs & Advocacy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert  Walker M.D.", "title": "Senior VP & Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 5, "compensationRisk": 7, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.92, "open": 8.05, "dayLow": 7.8027, "dayHigh": 8.54, "regularMarketPreviousClose": 7.92, "regularMarketOpen": 8.05, "regularMarketDayLow": 7.8027, "regularMarketDayHigh": 8.54, "payoutRatio": 0.0, "beta": 2.125, "forwardPE": -49.9375, "volume": 9161023, "regularMarketVolume": 9161023, "averageVolume": 3876547, "averageVolume10days": 2850690, "averageDailyVolume10Day": 2850690, "bid": 7.98, "ask": 8.0, "bidSize": 1, "askSize": 1, "marketCap": 1279878016, "fiftyTwoWeekLow": 3.81, "fiftyTwoWeekHigh": 23.86, "priceToSalesTrailing12Months": 1.4458745, "fiftyDayAverage": 8.7132, "twoHundredDayAverage": 11.3121, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 621359168, "profitMargins": -0.3218, "floatShares": 135084005, "sharesOutstanding": 160184992, "sharesShort": 34935605, "sharesShortPriorMonth": 36917946, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.2181, "heldPercentInsiders": 0.08748, "heldPercentInstitutions": 0.60412, "shortRatio": 7.17, "shortPercentOfFloat": 0.272, "impliedSharesOutstanding": 160184992, "bookValue": -3.287, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -284857984, "trailingEps": -2.18, "forwardEps": -0.16, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.702, "enterpriseToEbitda": -2.554, "52WeekChange": 0.4971645, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 7.99, "targetHighPrice": 25.0, "targetLowPrice": 9.0, "targetMeanPrice": 16.0, "targetMedianPrice": 15.5, "recommendationMean": 2.33333, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 909531008, "totalCashPerShare": 5.678, "ebitda": -243246000, "totalDebt": 262224992, "quickRatio": 0.89, "currentRatio": 0.935, "totalRevenue": 885193024, "revenuePerShare": 6.186, "returnOnAssets": -0.10759, "grossProfits": 115461000, "freeCashflow": -247394256, "operatingCashflow": -90881000, "revenueGrowth": -0.548, "grossMargins": 0.13044, "ebitdaMargins": -0.27479, "operatingMargins": -1.5360899, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "marketState": "REGULAR", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "regularMarketChange": 0.069999695, "regularMarketDayRange": "7.8027 - 8.54", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3876547, "fiftyTwoWeekLowChange": 4.18, "fiftyTwoWeekLowChangePercent": 1.0971128, "fiftyTwoWeekRange": "3.81 - 23.86", "fiftyTwoWeekHighChange": -15.870001, "fiftyTwoWeekHighChangePercent": -0.66512996, "fiftyTwoWeekChangePercent": 49.71645, "dividendDate": 1557446400, "earningsTimestamp": 1740663000, "earningsTimestampStart": 1740663000, "earningsTimestampEnd": 1740663000, "earningsCallTimestampStart": 1740663000, "earningsCallTimestampEnd": 1740663000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.18, "epsForward": -0.16, "epsCurrentYear": -1.51, "priceEpsCurrentYear": -5.2913904, "regularMarketChangePercent": 0.88383454, "regularMarketPrice": 7.99, "corporateActions": [], "regularMarketTime": 1740171070, "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "fiftyDayAverageChange": -0.72319984, "fiftyDayAverageChangePercent": -0.08300049, "twoHundredDayAverageChange": -3.3221006, "twoHundredDayAverageChangePercent": -0.29367673, "priceToBook": -2.430788, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]